Requirement for registration of clinical trials  by Cronenwett, Jack L. & Seeger, James M.
ANNOUNCEMENT
Requirement for registration of clinical trials
Jack L. Cronenwett, M.D., and James M. Seeger, M.D., Editors
In 2004, the International Committee of Medical Jour-
nal Editors (ICMJE) recommended that clinical trials be
registered in a public database as a prerequisite for subse-
quent publication.1 The primary rationale for this recom-
mendation was to assure the honest reporting of all clinical
trials, including those with results that might “reflect unfa-
vorably on a research sponsor’s product.”1 In addition, a
prospective registry of clinical trials would inform the sci-
entific community, facilitate collaboration, and avoid du-
plication. Member journals of the ICMJE initiated this
pre-registration requirement in July, 2005 for clinical trials
“that prospectively assign human subjects to intervention
or comparison groups to study the cause and effect rela-
tionship between a medical intervention and a health out-
come.”1 In 2005, the ICMJE clarified that “a trial must
have at least one concurrent control or comparison group
in order to trigger the requirement for registration.”2
Since public registration requirements were established
by the ICJME the principle site of registration for this
purpose has been sponsored by the National Library of
Medicine (NLM) at www.clinicaltrials.gov. This site pro-
vides public access and registration at no charge and con-
tains the minimal data required, including a unique identi-
fying number and a statement of hypothesis, study design,
outcome measures, eligibility, study dates, sponsor, and
contact information. The 20 required data elements for
trial registration recommended by the World Health Orga-
nization have recently been described in detail and are
included on the NLM site.2 Detailed directions and a
tutorial for registering a trial are available at http://prsinfo.
clinicaltrials.gov.
Effective July 1, 2007 the Journal of Vascular Surgery
will adopt the policies recommended by the ICMJE and
require the pre-registration of prospective clinical trials that
have a control group. In addition, the Journal will also
require the pre-registration of any commercially sponsored
clinical trial, including Phase I and II trials. We believe this
is important because many preliminary clinical trials test
new drugs or devices and require the same altruistic patient
volunteerism as Phase III trials. They deserve to be publicly
registered. We do not anticipate registration of retro-
spective reviews or summaries of standard clinical treat-
ment, although registration of any trial that is approved
by a human studies review board is permitted at www.
clinicaltrials.gov.
Clinical trials that meet the above requirement and
commence after July 1, 2007 must be registered prior to
enrollment of the first patient. Relevant trials that began
before this date must be registered prior to editorial review.
Registration must be indicated by providing the unique
study number assigned at www.clinicaltrials.gov. Further,
data fields must be appropriately completed in this registry
to provide sufficient information to clearly understand the
intent of the trial. Authors of unregistered trials or those
with inadequate information in the registry will be given an
opportunity convince the Editors that their rationale for
omitting this was critical, but it is our expectation that
clinical trials involving prospective comparison of treatment
or any that are commercially sponsored will all be registered
after July 1, 2007.
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